Holen Sie sich die Stockscreener-App
35.15
1.15%
0.40
Handel nachbörslich:
35.31
0.16
+0.46%
Tempus Ai Inc Aktie (TEM) Neueste Nachrichten
Tempus AI shares set to rally as Pelosi buys calls - Investing.com
Tempus AI, Inc. Majority Shareholder Sells $33M Worth of Stock - The Africa Logistics
Tempus AI, Inc : Good timing to go long again -January 20, 2025 at 11:06 am EST - Marketscreener.com
Tempus AI announces national launch of FDA-approved xT CDx test - MSN
TEM Insider Trade Alert! Majority Shareholder Sells $33M Worth of Tempus AI Stock - TipRanks
Avanza Fonder AB Purchases Shares of 35,414 Tempus AI, Inc. (NASDAQ:TEM) - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock - MSN
Tempus AI Stock Plunges 28.9% in Three Months: What's Next? - MSN
Tempus AI Inc (TEM): AI-Driven Healthcare Revolution - Insider Monkey
10 Must-Watch AI Stocks on Investors’ Radar - Insider Monkey
Cathie Wood's Ark Invest Is Betting Big On This AI Darling And No It's Not Nvidia - Benzinga
Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Bradley A. Keywell Sells 265,000 Shares - MarketBeat
Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 170,720 Shares of Stock - MarketBeat
Tempus AI's Bradley Keywell sells $33.1 million in stock By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Shares Up 11.7%Should You Buy? - MarketBeat
30,486 Shares in Tempus AI, Inc. (NASDAQ:TEM) Acquired by Bouvel Investment Partners LLC - MarketBeat
Tempus AI, Inc. Announces the National Launch of FDA-Approved xT CDx Test -January 15, 2025 at 08:30 am EST - Marketscreener.com
Tempus AI, Inc. (NASDAQ:TEM) Short Interest Update - MarketBeat
Tempus AI Leads Wednesday’s Rally with FDA-Approved Diagnostic Device Launch – Market - HPBL
Why Tempus AI (TEM) Is Among Wednesday’s Top Gainers? - MSN
Tempus AI (NASDAQ:TEM) Stock Price Down 7.9%Should You Sell? - MarketBeat
Tempus AI (NASDAQ:TEM) Stock Price Up 11.7%Still a Buy? - MarketBeat
Tempus AI Shares Rise on Launch of Cancer-Profiling Device - MarketWatch
Tempus AI (NASDAQ:TEM) Shares Gap DownShould You Sell? - MarketBeat
Tempus Announces the National Launch of FDA-Approved xT CDx Test - Marketscreener.com
Tempus AI Launches FDA-Approved 648-Gene Cancer Diagnostic Test Nationwide - StockTitan
Tempus AI: Disappointing Q4 Preliminary Results, But Bullish Fundamental Update - Seeking Alpha
Tempus AI shares rated Buy by Loop Capital, target cut as Compass CRO softness weighs on guidance - Investing.com Canada
TEM Stock Declines Following Preliminary Q4 Sales Miss - MSN
Tempus announces preliminary fourth quarter revenue, shares fall - MSN
Tempus AI (TEM) Launches AI-Powered Whole-Genome Sequencing Test to Transform Precision Medicine - Insider Monkey
15 Important AI News and Ratings on Investors’ Radar - Insider Monkey
Loop Capital Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
JPM25, Day 2: News from Nvidia, Tempus AI and Health Catalyst; A look at Children's Health Dallas' expansion plans - Fierce healthcare
Needham & Company LLC Reiterates "Buy" Rating for Tempus AI (NASDAQ:TEM) - MarketBeat
Tempus AI Revolutionizes Healthcare with Advanced Generative AI Platform Upgrade - StockTitan
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock - Benzinga
Lefkofsky, touting strong financials for Tempus, paints a rosy future for AI and medicine - Crain's Chicago Business
Cathie Wood's ARK Snaps Up Tempus AI Shares Despite Revenue Miss and Market Sell-Off - GuruFocus.com
Cathie Wood’s ARKG Loads Up on Tempus AI (NASDAQ:TEM) as Stock Plunges on Revenue Miss - TipRanks
Here’s Why Tempus AI, Inc (TEM) Is Among Monday’s Top Losers - MSN
Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 - Benzinga
SB TEMPUS Signs Agreement with Konica Minolta To Acquire Shares of Konica Minolta REALM - Konica Minolta
10 Firms Drop on Bearish Statements, Disappointing Earnings - Insider Monkey
Tempus AI unveils whole-genome sequencing test for cancer By Investing.com - Investing.com Canada
Tempus AI Reports Preliminary 2024 Revenue of $693 Million, Shares Fall Over 14% - Yahoo Finance
Tempus AI reports 30% annual revenue growth in 2024 By Investing.com - Investing.com Australia
Tempus AI Shares Fall 11.7% After 4Q Revenue Projections Fall Below Expectations - MarketWatch
Tempus AI reports 30% annual revenue growth in 2024 - Investing.com
0.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):